YU49227B - Postupak za dobijanje n-amino-1-hidroksi-alkiliden-1,1-bisfosfonskih kiselina - Google Patents
Postupak za dobijanje n-amino-1-hidroksi-alkiliden-1,1-bisfosfonskih kiselinaInfo
- Publication number
- YU49227B YU49227B YU51694A YU51694A YU49227B YU 49227 B YU49227 B YU 49227B YU 51694 A YU51694 A YU 51694A YU 51694 A YU51694 A YU 51694A YU 49227 B YU49227 B YU 49227B
- Authority
- YU
- Yugoslavia
- Prior art keywords
- hydroksi
- alkil
- idene
- producting
- amino
- Prior art date
Links
- 239000002253 acid Substances 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- 230000001419 dependent effect Effects 0.000 abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6564—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
- C07F9/6571—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/3804—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
- C07F9/3839—Polyphosphonic acids
- C07F9/3873—Polyphosphonic acids containing nitrogen substituent, e.g. N.....H or N-hydrocarbon group which can be substituted by halogen or nitro(so), N.....O, N.....S, N.....C(=X)- (X =O, S), N.....N, N...C(=X)...N (X =O, S)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/576—Six-membered rings
- C07F9/58—Pyridine rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6564—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
- C07F9/6571—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms
- C07F9/657163—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms the ring phosphorus atom being bound to at least one carbon atom
- C07F9/657181—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms the ring phosphorus atom being bound to at least one carbon atom the ring phosphorus atom and, at least, one ring oxygen atom being part of a (thio)phosphonic acid derivative
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Jedinjenje, naznačeno time, što ima strukturnu formulu I Z-R1 I gde je Z odabrano iz grupe koja se sastoji od: a) H2N-C2-5alkil-; b) gde je R5- = C1-5alkil, i Y je odabrano od (i) vodonika; (ii) C1-5alkil; (iii) R6O; (iv) R6S; (v) R6R6N; (vi) halogena R6 je H ili C1-5alkil; i c) C2-6alkil-(N-CH3)C2H4-: i R1 je odabrano iz grupe koja se sastoji od: gde je X = -OH ili Cl. Prijava sadrži još 7 zavisnih, 2 nezavisna i 11 zavisnih patentnih zahteva.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11175193A | 1993-08-25 | 1993-08-25 | |
US08/286,151 US5510517A (en) | 1993-08-25 | 1994-08-04 | Process for producing N-amino-1-hydroxy-alkylidene-1,1-bisphosphonic acids |
Publications (2)
Publication Number | Publication Date |
---|---|
YU51694A YU51694A (sh) | 1997-09-30 |
YU49227B true YU49227B (sh) | 2004-11-25 |
Family
ID=27381052
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
YU51694A YU49227B (sh) | 1993-08-25 | 1994-08-24 | Postupak za dobijanje n-amino-1-hidroksi-alkiliden-1,1-bisfosfonskih kiselina |
Country Status (5)
Country | Link |
---|---|
US (1) | US5648491A (sh) |
KR (1) | KR100258283B1 (sh) |
TW (1) | TW257765B (sh) |
UA (1) | UA54368C2 (sh) |
YU (1) | YU49227B (sh) |
Families Citing this family (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1088333A4 (en) | 1998-06-24 | 2005-08-10 | Merck & Co Inc | METHOD AND COMPOSITIONS FOR CONNECTING OSTEOPROSIS |
US20030078211A1 (en) * | 1998-06-24 | 2003-04-24 | Merck & Co., Inc. | Compositions and methods for inhibiting bone resorption |
US6331533B1 (en) | 1998-11-16 | 2001-12-18 | Merck & Co., Inc. | Method for inhibiting dental resorptive lesions |
ES2153794B1 (es) | 1999-08-06 | 2001-10-16 | Medichem Sa | Procedimiento para la obtencion del acido 4-amino-1-hidroxibutiliden-1,1-bisfosfonico y de su sal monosodica trihidratada. |
US6410520B2 (en) * | 2000-02-01 | 2002-06-25 | The Procter & Gamble Company | Selective crystallization of 3-pyridyl-1-hydroxyethylidene-1, 1-bisphosphonic acid sodium as the hemipentahydrate or monohydrate |
US6476006B2 (en) | 2000-06-23 | 2002-11-05 | Teva Pharmaceutical Industries, Ltd. | Composition and dosage form for delayed gastric release of alendronate and/or other bis-phosphonates |
US7038083B2 (en) * | 2002-05-17 | 2006-05-02 | Teva Pharmaceutical Industries, Ltd. | Process for making bisphosphonic acids using diluents other than halogenated hydrocarbons |
EP1513523A1 (en) * | 2002-06-06 | 2005-03-16 | Merck Frosst Canada & Co. | 1,5-disubstituted imidazolidin-2-one derivatives for use as ep4 receptor agonists in the treatment of eye and bone diseases |
JP4485117B2 (ja) * | 2002-06-27 | 2010-06-16 | 日東電工株式会社 | 保護剥離用フィルム |
JP2006504679A (ja) * | 2002-08-28 | 2006-02-09 | メルク フロスト カナダ アンド カンパニー | 緑内障の治療においてep4受容体作動薬として使用するためのオキサゾリジン−2−オンおよびチアゾリジン−2−オン誘導体 |
US20040138180A1 (en) * | 2002-10-03 | 2004-07-15 | Barr Laboratories, Inc. | Bisphosphonate composition and process for the preparation thereof |
US20040206932A1 (en) * | 2002-12-30 | 2004-10-21 | Abuelyaman Ahmed S. | Compositions including polymerizable bisphosphonic acids and methods |
CA2535556C (en) * | 2003-08-12 | 2014-01-07 | 3M Innovative Properties Company | Self-etching dental compositions and methods |
CA2535359A1 (en) | 2003-08-21 | 2005-03-03 | Merck Frosst Canada Ltd. | Cathepsin cysteine protease inhibitors |
WO2005027921A1 (en) * | 2003-09-19 | 2005-03-31 | Pfizer Products Inc. | Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin d derivatives and a bisphosphonate |
UA87854C2 (en) | 2004-06-07 | 2009-08-25 | Мерк Энд Ко., Инк. | N-(2-benzyl)-2-phenylbutanamides as androgen receptor modulators |
US8465284B2 (en) | 2004-07-08 | 2013-06-18 | 3M Innovative Properties Company | Dental methods, compositions, and kits including acid-sensitive dyes |
WO2006020760A1 (en) | 2004-08-11 | 2006-02-23 | 3M Innovative Properties Company | Self-adhesive compositions including a plurality of acidic compounds |
PL1855674T3 (pl) | 2005-03-02 | 2015-01-30 | Merck Sharp & Dohme | Kompozycja do hamowania katepsyny K |
WO2006134603A1 (en) * | 2005-06-13 | 2006-12-21 | Jubilant Organosys Limited | Process for producing bisphosphonic acids and forms thereof |
JP5354858B2 (ja) * | 2006-05-09 | 2013-11-27 | 株式会社Adeka | スルホンアミド化合物の金属塩を含有するポリエステル樹脂組成物 |
EP2016084A2 (en) | 2006-05-11 | 2009-01-21 | Ind-Swift Laboratories Limited | Process for the preparation of pure risedronic acid or salts |
CN101557791B (zh) * | 2006-12-13 | 2013-05-22 | 3M创新有限公司 | 使用具有酸性组分和可光漂白染料的牙科用组合物的方法 |
PL2222636T3 (pl) | 2007-12-21 | 2014-04-30 | Ligand Pharm Inc | Selektywne modulatory receptorów androgenowych (SARM) i ich zastosowania |
WO2011039378A1 (en) | 2009-10-02 | 2011-04-07 | Straitmark Holding Ag | Method for the manufacture of aminohydroxy diphosphonic acids |
CA2738045C (en) | 2010-05-28 | 2019-02-19 | Simon Fraser University | Conjugate compounds, methods of making same, and uses thereof |
WO2012112363A1 (en) | 2011-02-14 | 2012-08-23 | Merck Sharp & Dohme Corp. | Cathepsin cysteine protease inhibitors |
WO2015051479A1 (en) | 2013-10-08 | 2015-04-16 | Merck Sharp & Dohme Corp. | Cathepsin cysteine protease inhibitors |
AU2014332250B2 (en) | 2013-10-08 | 2018-07-19 | Merck Sharp & Dohme Corp. | Cathepsin cysteine protease inhibitors |
WO2015120580A1 (en) | 2014-02-11 | 2015-08-20 | Merck Sharp & Dohme Corp. | Cathepsin cysteine protease inhibitors |
EP3148587B1 (en) | 2014-05-30 | 2021-02-24 | Pfizer Inc | Carbonitrile derivatives as selective androgen receptor modulators |
US9650414B1 (en) | 2014-05-30 | 2017-05-16 | Simon Fraser University | Dual-action EP4 agonist—bisphosphonate conjugates and uses thereof |
WO2016199111A1 (en) | 2015-06-12 | 2016-12-15 | Simon Fraser University | Amide-linked ep4 agonist-bisphosphonate compounds and uses thereof |
EP3827010A4 (en) | 2018-07-23 | 2022-03-16 | Brise Pharmaceuticals Co., Ltd. | BISPHOSPHONATE-DRUG CONJUGATES |
WO2023275715A1 (en) | 2021-06-30 | 2023-01-05 | Pfizer Inc. | Metabolites of selective androgen receptor modulators |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3016289A1 (de) * | 1980-04-28 | 1981-10-29 | Henkel KGaA, 4000 Düsseldorf | Verfahren zur herstellung von omega -amino-1-hydroxyalkyliden-1,1-bis-phosphonsaeuren |
US4922007A (en) * | 1989-06-09 | 1990-05-01 | Merck & Co., Inc. | Process for preparing 4-amino-1-hydroxybutylidene-1,1-bisphosphonic acid or salts thereof |
US5019651A (en) * | 1990-06-20 | 1991-05-28 | Merck & Co., Inc. | Process for preparing 4-amino-1-hydroxybutylidene-1,1-bisphosphonic acid (ABP) or salts thereof |
-
1994
- 1994-08-17 TW TW083107554A patent/TW257765B/zh not_active IP Right Cessation
- 1994-08-24 KR KR1019960700883A patent/KR100258283B1/ko not_active IP Right Cessation
- 1994-08-24 UA UA96020672A patent/UA54368C2/uk unknown
- 1994-08-24 YU YU51694A patent/YU49227B/sh unknown
- 1994-08-24 US US08/617,851 patent/US5648491A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
UA54368C2 (uk) | 2003-03-17 |
YU51694A (sh) | 1997-09-30 |
US5648491A (en) | 1997-07-15 |
KR100258283B1 (ko) | 2000-07-01 |
TW257765B (sh) | 1995-09-21 |
KR960703932A (ko) | 1996-08-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
YU49227B (sh) | Postupak za dobijanje n-amino-1-hidroksi-alkiliden-1,1-bisfosfonskih kiselina | |
MY109937A (en) | Substituted azoles, processes for the preparation thereof, agents containing these, and the use thereof. | |
TW341573B (en) | New erythromycin derivatives, their preparation process and their use as medicaments | |
EP0528858A4 (en) | Inhibitors of dipeptidyl-aminopeptidase type iv | |
AU5286686A (en) | Novel heterocyclic compounds | |
ATE131863T1 (de) | Verwendung von halogenkohlenwasserstofflösungsmittel als reinigungsmittel | |
PL295030A1 (en) | Method of obtaining substituted derivatives of 2-cyclohexan-1-yl amine | |
SE8704599L (sv) | Teobrominderivat | |
MX9606331A (es) | Nuevos compuestos, procesos para la preparacion de los mismos y agentes antitumor. | |
TR199901282T2 (xx) | Heterosiklik olarak ikame edilmi� yeni benzamitler. | |
EA199800109A1 (ru) | Производные азетидинона для лечения атеросклероза | |
YU85691A (sh) | Nove sulfonilne spojine | |
SG52766A1 (en) | Organic compounds | |
TW223630B (en) | Retroviral protease inhibitors | |
MY107819A (en) | Preparation of substituted piperidines. | |
AU8837482A (en) | Heterocyclic substituted phenylsulfonylurea derivatives | |
NO952610L (no) | Pyridonkarboksylsyrederivater | |
GR3023757T3 (en) | Cyclic benzylamino, benzylamido and benzylimido derivatives as antipsychotic agents. | |
ES8502435A1 (es) | Un metodo para preparar 2(1h)-piridinonas | |
ES2103794T3 (es) | Pirazolinas, pirazolidinas e hidrazinas artropodicidas. | |
ZA91288B (en) | Coating compound,process for its production as well as use thereof | |
ZA9410287B (en) | N-oxides of 4-arylpiperazines and 4-arylpiperidines | |
AU3350195A (en) | Bicyclic carboxamides as 5-HT-1A antagonists | |
ES479033A1 (es) | Un procedimiento para la preparacion de derivados de n-iminometil piperidina. | |
YU49004B (sh) | LANOSTA-7,9-DIEN-3Гџ, 32-DIOL I POSTUPAK ZA NJEGOVO DOBIJANJE |